Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase

Study Questions:

What is the clinical impact of delays in transfer for primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) compared with onsite fibrinolytic therapy in routine clinical practice?